IL-7/CD80-expressing allogeneic RCC-26 tumor cell vaccine (Charite Universitaetsmedizin Berlin)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIL-7/CD80-expressing allogeneic RCC-26 tumor cell vaccine (Charite Universitaetsmedizin Berlin)

Drug Alias NameRCC26/IL-7/CD80RCC-26/IL-7/CD80

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Renal Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCharite Universitaetsmedizin Berlin

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCharite Universitaetsmedizin Berlin

Active IndicationsN/A

Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A